INOZYME PHARMA, INC. Restricted Cash, Noncurrent
INOZYME PHARMA, INC. had Restricted Cash, Noncurrent of $0 as of 2024-12-31, per its 10-K filed 2025-03-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashNoncurrent · last filed 2025-03-10
- 2024-12-31: Restricted Cash, Noncurrent $0.00.
- 2024-09-30: Restricted Cash, Noncurrent $311.00K.
- 2024-06-30: Restricted Cash, Noncurrent $311.00K.
- 2024-03-31: Restricted Cash, Noncurrent $311.00K.
| Period end | Restricted Cash, Noncurrent |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-10 |
| 2024-09-30 | $311.00K 10-Q · filed 2024-11-05 |
| 2024-06-30 | $311.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $311.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $311.00K 10-K · filed 2025-03-10 |
| 2023-09-30 | $311.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $311.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $354.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $354.00K 10-K · filed 2024-03-12 |
| 2022-03-31 | $354.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $354.00K 10-Q · filed 2022-05-10 |
| 2021-09-30 | $354.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $354.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $354.00K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $354.00K 10-K · filed 2022-03-15 |
| 2020-09-30 | $354.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $355.00K 10-Q · filed 2020-09-03 |
| 2019-12-31 | $130.00K 10-K · filed 2021-03-25 |